Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?

Angelos Kyriacou
, Eka Melson
, Wentin Chen
, Punith Kempegowda

Metabolism and Systems Science

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	417-423
Journal	Clinical Medicine
Volume	20
Issue number	4
DOIs	https://doi.org/10.7861/clinmed.2020-0054
Publication status	Accepted/In press - 1 Apr 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.7861/clinmed.2020-0054

Cite this

@article{c4d64a9155434d7cb593de56f738e704,

title = "Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?",

author = "Angelos Kyriacou and Eka Melson and Wentin Chen and Punith Kempegowda",

year = "2020",

month = apr,

day = "1",

doi = "10.7861/clinmed.2020-0054",

language = "English",

volume = "20",

pages = "417--423",

journal = "Clinical Medicine",

issn = "1470-2118",

publisher = "Royal College of Physicians",

number = "4",

}

TY - JOUR

T1 - Is immune checkpoint inhibitor-associated diabetes the same as fulminant type 1 diabetes mellitus?

AU - Kyriacou, Angelos

AU - Melson, Eka

AU - Chen, Wentin

AU - Kempegowda, Punith

PY - 2020/4/1

Y1 - 2020/4/1

UR - https://www.scopus.com/pages/publications/85088157207

U2 - 10.7861/clinmed.2020-0054

DO - 10.7861/clinmed.2020-0054

M3 - Article

SN - 1470-2118

VL - 20

SP - 417

EP - 423

JO - Clinical Medicine

JF - Clinical Medicine

IS - 4

ER -